Direct oral anticoagulants: the safer choice in chronic kidney disease?

被引：1
作者：
Mavrakanas, Thomas A. [1 ,2 ]
机构：
[1] McGill Univ, Hlth Ctr, Dept Med, Div Nephrol, Montreal, PQ, Canada
[2] MUHC Res Inst, 2B 44-5252 Maisonneuve W, Montreal, PQ, Canada
来源：
CLINICAL KIDNEY JOURNAL | 2024年 / 17卷 / 01期
关键词：
RENAL-FUNCTION; ATRIAL-FIBRILLATION; WARFARIN; INSIGHTS;
D O I：
10.1093/ckj/sfad288
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 9 条
[1]   Changes in Renal Function in Patients With Atrial Fibrillation An Analysis From the RE-LY Trial [J].
Boehm, Michael ;
Ezekowitz, Michael D. ;
Connolly, Stuart J. ;
Eikelboom, John W. ;
Hohnloser, Stefan H. ;
Reilly, Paul A. ;
Schumacher, Helmut ;
Brueckmann, Martina ;
Schirmer, Stephan H. ;
Kratz, Mario T. ;
Yusuf, Salim ;
Diener, Hans-Christoph ;
Hijazi, Ziad ;
Wallentin, Lars .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (23) :2481-2493
[2]   Anticoagulant-Related Nephropathy [J].
Brodsky, Sergey ;
Eikelboom, John ;
Hebert, Lee A. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 29 (12) :2787-2793
[3]   Acute Kidney Injury During Warfarin Therapy Associated With Obstructive Tubular Red Blood Cell Casts: A Report of 9 Cases [J].
Brodsky, Sergey V. ;
Satoskar, Anjali ;
Chen, Jun ;
Nadasdy, Gyongyi ;
Eagen, Jeremiah W. ;
Hamirani, Mirza ;
Hebert, Lee ;
Calomeni, Edward ;
Nadasdy, Tibor .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 54 (06) :1121-1126
[4]   On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin Insights From ROCKET AF [J].
Fordyce, Christopher B. ;
Hellkamp, Anne S. ;
Lokhnygina, Yuliya ;
Lindner, Samuel M. ;
Piccini, Jonathan P. ;
Becker, Richard C. ;
Berkowitz, Scott D. ;
Breithardt, Guenter ;
Fox, Keith A. A. ;
Mahaffey, Kenneth W. ;
Nessel, Christopher C. ;
Singer, Daniel E. ;
Patel, Manesh R. .
CIRCULATION, 2016, 134 (01) :37-+
[5]   Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time Insights From the ARISTOTLE Randomized Clinical Trial [J].
Hijazi, Ziad ;
Hohnloser, Stefan H. ;
Andersson, Ulrika ;
Alexander, John H. ;
Hanna, Michael ;
Keltai, Matyas ;
Parkhomenko, Alexander ;
Lopez-Sendon, Jose L. ;
Lopes, Renato D. ;
Siegbahn, Agneta ;
Granger, Christopher B. ;
Wallentin, Lars .
JAMA CARDIOLOGY, 2016, 1 (04) :451-460
[6]   The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism [J].
Mavrakanas, Thomas ;
Bounameaux, Henri .
PHARMACOLOGY & THERAPEUTICS, 2011, 130 (01) :46-58
[7]   Direct oral anticoagulants in chronic kidney disease: an update [J].
Mavrakanas, Thomas A. ;
Charytan, David M. ;
Winkelmayer, Wolfgang C. .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (05) :489-496
[8]   Oral anticoagulant treatment and risk of kidney disease-a nationwide, population-based cohort study [J].
Vestergaard, Ane Emilie Friis ;
Jensen, Simon Kok ;
Heide-Jorgensen, Uffe ;
Adelborg, Kasper ;
Birn, Henrik ;
Carrero, Juan-Jesus ;
Christiansen, Christian Fynbo .
CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
[9]   Warfarin-Related Nephropathy Modeled by Nephron Reduction and Excessive Anticoagulation [J].
Ware, Kyle ;
Brodsky, Polina ;
Satoskar, Anjali A. ;
Nadasdy, Tibor ;
Nadasdy, Gyongyi ;
Wu, Haifeng ;
Rovin, Brad H. ;
Bhatt, Udayan ;
Von Visger, Jon ;
Hebert, Lee A. ;
Brodsky, Sergey V. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 22 (10) :1856-1862
1